Abbvie Inc (NYSE:ABBV) under-valued by 26%
| Website | https://www.abbvie.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $204,616,581,120 |
| Beta | 0.805347 |
| Average Volume | $6,960,860 |
| Last Dividend | 4.96% |
| Price on Aug 4, 2022 | $142.08 |
| Autochartist™ Valuation | $178.91 |
| Conclusion |
26% under-valued |
| Download Report |
